Success Metrics

Clinical Success Rate
40.0%

Based on 2 completed trials

Completion Rate
40%(2/5)
Active Trials
2(25%)
Results Posted
150%(3 trials)
Terminated
3(38%)

Phase Distribution

Ph not_applicable
5
63%
Ph phase_1
1
13%
Ph phase_4
1
13%
Ph phase_2
1
13%

Phase Distribution

1

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
Phase 2Efficacy & side effects
1(12.5%)
Phase 4Post-market surveillance
1(12.5%)
N/ANon-phased studies
5(62.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

40.0%

2 of 5 finished

Non-Completion Rate

60.0%

3 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(2)
Completed(2)
Terminated(3)
Other(1)

Detailed Status

Terminated3
Active, not recruiting2
Completed2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
40.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (12.5%)
Phase 21 (12.5%)
Phase 41 (12.5%)
N/A5 (62.5%)

Trials by Status

unknown113%
terminated338%
active_not_recruiting225%
completed225%

Recent Activity

2 active trials
Showing 5 of 8
active_not_recruitingnot_applicable

Investigation of Prostate Artery Embolization Compared to Holmium Laser Enucleation of Prostate

NCT05155891
completednot_applicable

Effectiveness and Safety of Embosphere Microspheres for Embolization of the Geniculate Artery for the Treatment of Pain With Known Moderate to Severe Knee Osteoarthritis

NCT05112926
active_not_recruitingnot_applicable

GAE Using Embosphere Microspheres vs Corticosteroid Injections for Treatment of Symptomatic Knee OA (MOTION)

NCT05818150
terminatednot_applicable

Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia

NCT01789840
terminatedphase_1

Prostate Embolization for Massive Benign Prostatic Hypertrophy (BPH)

NCT02676544
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT05155891Not Applicable

Investigation of Prostate Artery Embolization Compared to Holmium Laser Enucleation of Prostate

Active Not Recruiting
NCT05112926Not Applicable

Effectiveness and Safety of Embosphere Microspheres for Embolization of the Geniculate Artery for the Treatment of Pain With Known Moderate to Severe Knee Osteoarthritis

Completed
NCT05818150Not Applicable

GAE Using Embosphere Microspheres vs Corticosteroid Injections for Treatment of Symptomatic Knee OA (MOTION)

Active Not Recruiting
NCT01789840Not Applicable

Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia

Terminated
NCT02676544Phase 1

Prostate Embolization for Massive Benign Prostatic Hypertrophy (BPH)

Terminated
NCT02167009Not Applicable

Benign Prostatic Hyperplasia and Prostate Size Greater Than 90 Grams

Unknown
NCT02396420Phase 2

Prostate Artery Embolization as a Treatment for Benign Prostatic Hyperplasia in Men With Prostates Larger Than 90 Grams

Terminated
NCT00628901Phase 4

A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE)

Completed

All 8 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
8